Peter Barton Hutt - Oct 14, 2022 Form 4 Insider Report for CONCERT PHARMACEUTICALS, INC. (CNCE)

Role
Director
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact
Stock symbol
CNCE
Transactions as of
Oct 14, 2022
Transactions value $
-$11,360
Form type
4
Date filed
10/18/2022, 04:25 PM
Previous filing
Jun 13, 2022
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNCE Common Stock Options Exercise $10.2K +3.54K +12% $2.88 33K Oct 14, 2022 Direct
transaction CNCE Common Stock Sale -$21.6K -3.54K -10.72% $6.09 29.5K Oct 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNCE Stock Option (right to buy) Options Exercise $0 -3.54K -100% $0.00* 0 Oct 14, 2022 Common Stock 3.54K $2.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested.